Efficacy and Safety of Kleeb Bua Daeng Formula in Mild Cognitive Impairment Patients: A Phase I Randomized, Double-Blind, Placebo-Controlled Trial

Individuals with mild cognitive impairment (MCI) were at increased risk of conversion to dementia. The Kleeb Bua Daeng (KBD) formula could be the alternative treatment option for MCI through multitarget activities. Lacking of clinical trial information brought about the study in our research. Forty...

Descripción completa

Detalles Bibliográficos
Autores principales: Musigavong, Natdanai, Boonyarat, Chantana, Chulikhit, Yaowared, Monthakantirat, Orawan, Limudomporn, Makorn, Pitiporn, Supaporn, Kwankhao, Pakakrong, Daodee, Supawadee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975679/
https://www.ncbi.nlm.nih.gov/pubmed/35368763
http://dx.doi.org/10.1155/2022/1148112

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975679/
https://www.ncbi.nlm.nih.gov/pubmed/35368763
http://dx.doi.org/10.1155/2022/1148112

Ejemplares similares